etiolog
morbid
associ
asthma
thought
stem
genet
factor
potenti
modifi
environment
factor
viral
infect
although
unclear
whether
respiratori
viral
infect
caus
asthma
observ
studi
demonstr
high
rate
asthma
children
histori
sever
viral
lower
respiratori
tract
infect
lrti
infanc
virus
associ
major
asthma
exacerb
among
children
adult
articl
discuss
pathogen
associ
virusinduc
wheez
ill
infanc
earli
childhood
associ
bronchiol
infanc
increas
risk
childhood
asthma
associ
respiratori
virus
asthma
exacerb
older
children
adult
overview
viral
bronchiol
lrti
typic
associ
cough
tachypnea
retract
diffus
wheez
rale
bronchiol
lead
caus
hospit
first
year
life
account
estim
infant
hospit
annual
infant
etiolog
agent
bronchiol
viral
respiratori
infect
associ
wheez
includ
respiratori
syncyti
viru
rsv
rhinoviru
influenza
parainfluenza
piv
adenoviru
recent
identifi
virus
human
metapneumoviru
hmpv
human
boca
viru
hbov
rsv
caus
epidem
bronchiol
typic
circul
temper
climat
novemb
april
peak
winter
month
tropic
climat
peak
relat
temperatur
level
rainfal
rsv
infect
major
children
first
year
life
essenti
children
show
evid
rsv
infect
age
year
initi
rsv
infect
typic
sever
caus
lower
respiratori
tract
diseas
bronchiol
infant
virus
rhinoviru
piv
adenoviru
circul
nearli
yearround
season
peak
ill
although
rsv
long
identifi
major
caus
infant
bronchiol
use
molecular
techniqu
polymeras
chain
reaction
pcr
assay
allow
sensit
detect
rhinoviru
virus
respiratori
infect
rhinoviru
circul
yearround
major
peak
autumn
spring
lead
caus
upper
respiratori
tract
infect
children
show
evid
rhinoviru
infect
age
year
although
rhinoviru
histor
thought
limit
upper
respiratori
tract
investig
demonstr
rhinoviru
infect
lower
airway
associ
infant
bronchiol
becom
domin
pathogen
wheez
ill
children
get
older
observ
studi
describ
viral
etiolog
bronchiol
wheez
ill
infant
young
children
tabl
first
descript
studi
viral
etiolog
bronchiol
primarili
use
detect
method
cell
cultur
antigen
detect
serolog
test
kim
colleagu
studi
epidemiolog
rsv
infect
infant
young
children
admit
children
hospit
washington
dc
found
children
bronchiol
evid
infect
rsv
norwegian
studi
investig
use
immunofluoresc
cell
cultur
investig
epidemiolog
respiratori
virus
young
children
admit
hospit
respiratori
ill
infant
diagnos
respiratori
viru
infect
rsv
account
diagnos
infect
rsv
infect
associ
lower
respiratori
tract
ill
studi
also
describ
typic
distribut
known
virus
time
includ
winter
epidem
rsv
influenza
late
winter
spring
season
distribut
rhinoviru
peak
autumn
spring
use
multipl
viru
detect
method
includ
pcr
jartti
colleagu
investig
etiolog
wheez
ill
hospit
children
finland
septemb
may
infant
studi
rsv
common
viru
detect
follow
picornaviru
hmpv
calvo
colleagu
studi
consecut
respiratori
admiss
children
less
year
age
singl
hospit
spain
septemb
juli
nasopharyng
sampl
obtain
children
viru
isol
subject
rsv
account
rhinoviru
adenoviru
influenza
hmpv
children
rhinoviru
detect
recurr
wheez
bronchiol
lead
diagnos
cohort
children
recruit
birth
allow
longitudin
followup
children
includ
less
sever
diseas
requir
hospit
tucson
children
respiratori
studi
birth
cohort
infant
enrol
may
januari
wright
colleagu
describ
epidemiolog
lrti
infanc
overal
infant
follow
first
year
life
total
children
contribut
lrti
evalu
physician
respiratori
cultur
obtain
initi
ill
cumul
incid
rate
lower
respiratori
tract
ill
first
year
life
per
children
one
percent
infant
hospit
ill
immunofluoresc
viral
cultur
employ
detect
infect
rsv
piv
type
influenza
b
adenoviru
enteroviru
cytomegaloviru
rhinoviru
infecti
agent
identifi
viral
cultur
avail
sampl
obtain
infant
lower
respiratori
tract
ill
rsv
account
first
bronchiol
diagnos
virus
detect
infant
bronchiol
diagnos
includ
piv
type
influenza
b
adenoviru
australian
cohort
infant
least
one
parent
doctordiagnos
atopi
recruit
infant
juli
juli
follow
first
year
life
nasopharyng
aspir
detail
inform
collect
prospect
acut
respiratori
ill
pcr
use
identifi
viral
respiratori
pathogen
acut
respiratori
ill
associ
wheez
rattli
chest
classifi
role
newli
identifi
virus
hmpv
hbov
infant
wheez
ill
still
defin
william
colleagu
investig
role
hmpv
lrti
children
enrol
birth
follow
age
year
vaccin
clinic
hmpv
first
identifi
detect
avail
sampl
obtain
children
lower
respiratori
tract
ill
respiratori
pathogen
previous
detect
hmpv
therefor
account
lower
respiratori
tract
ill
cohort
otherwis
healthi
young
children
kesebir
colleagu
use
avail
respiratori
specimen
submit
hospitalbas
clinic
virolog
laboratori
januari
decemb
investig
preval
hbov
first
identifi
hbov
detect
studi
sampl
obtain
children
less
year
age
neg
virus
although
test
rhinoviru
perform
wheez
ill
associ
approxim
hbovassoci
case
alland
colleagu
found
hbov
sole
viru
isol
approxim
respiratori
sampl
children
year
age
hospit
acut
wheez
gener
use
sensit
molecular
techniqu
confirm
major
role
rsv
infant
bronchiol
broaden
role
virus
previous
difficult
detect
cultur
allow
identif
new
respiratori
virus
furthermor
studi
use
pcr
demonstr
rsv
appear
viru
commonli
associ
wheez
infant
rhinoviru
play
promin
role
age
year
epidemiolog
studi
infant
children
highlight
import
rsvassoci
wheez
infant
rhinovirusassoci
wheez
older
children
rake
colleagu
conduct
crosssect
studi
children
present
emerg
depart
wheez
januari
april
compar
control
present
emerg
depart
nonrespiratori
complaint
period
respiratori
virus
isol
wheez
children
less
year
age
rsv
common
viru
detect
children
less
year
age
detect
control
subject
howev
children
less
year
age
similar
proport
nasal
aspir
wheez
control
posit
rhinoviru
children
older
year
virus
detect
wheez
respiratori
viral
infect
asthma
children
rhinoviru
detect
pcr
wheez
older
children
compar
nonwheez
control
rsv
detect
wheez
children
year
older
addit
investig
found
wheez
children
year
older
posit
test
rhinoviru
measur
marker
atopi
compar
respect
control
group
similar
studi
children
month
year
admit
hospit
wheez
compar
agematch
control
admit
without
wheez
younger
children
viru
detect
wheez
children
compar
respect
control
consist
studi
rsv
predomin
viru
younger
children
winter
howev
rhinoviru
detect
frequent
young
children
hospit
wheez
april
novemb
among
children
older
year
respiratori
viru
significantli
like
detect
children
admit
wheez
children
without
wheez
rhinoviru
detect
significantli
associ
wheez
addit
wheez
strongli
associ
atopi
measur
total
ige
skin
test
children
older
year
studi
highlight
differ
pathogen
associ
wheez
ill
age
associ
rhinoviru
atopi
wheez
children
beyond
infanc
associ
viralassoci
wheez
ill
infanc
subsequ
childhood
asthma
associ
bronchiol
infanc
develop
asthma
area
interest
decad
previou
studi
primarili
includ
case
infant
hospit
bronchiol
infanc
therefor
studi
examin
wheez
hospit
bronchiol
infanc
may
reflect
outcom
larg
major
infant
bronchiol
outpati
visit
emerg
depart
visit
health
care
visit
although
sever
earli
studi
focus
sole
rsv
bronchiol
conduct
routin
test
rhinoviru
avail
recent
studi
use
pcr
investig
associ
nonrsv
bronchiol
subsequ
wheez
therefor
divers
group
research
investig
area
includ
case
infant
specif
viral
agent
bronchiol
determin
case
infant
rsv
bronchiol
case
infant
either
rsv
nonrsv
bronchiol
overal
convinc
evid
sever
cohort
rsv
rhinoviru
bronchiol
infanc
risk
factor
marker
subsequ
wheez
within
first
decad
life
hospit
bronchiol
infanc
associ
recurr
wheez
asthma
childhood
rsv
known
major
caus
bronchiol
infanc
sever
earli
cohort
includ
case
infant
hospit
rsv
bronchiol
infanc
sigur
colleagu
studi
relationship
rsv
hospit
infanc
asthma
small
cohort
swedish
children
prospect
studi
includ
children
hospit
rsv
bronchiol
infanc
match
control
investig
defin
studi
outcom
asthma
three
episod
bronchial
obstruct
verifi
physician
recurr
wheez
three
episod
bronchial
obstruct
physician
verifi
wheez
asthma
recurr
wheez
one
two
episod
wheez
age
year
approxim
one
third
children
histori
sever
rsv
bronchiol
diagnos
asthma
children
significantli
like
diagnosi
asthma
nonhospit
control
though
cohort
small
evid
studi
point
likelihood
increas
risk
asthma
age
among
children
histori
sever
rsv
bronchiol
infanc
histor
data
also
demonstr
increas
risk
wheez
asthma
nonrsv
bronchiol
emerg
data
suggest
children
histori
lrti
virus
rsv
may
even
greater
risk
subsequ
wheez
earli
studi
hospit
children
less
year
age
simon
jordan
specul
children
nonrsv
bronchiol
predisposit
develop
asthma
murray
colleagu
conduct
investig
children
either
rsv
nonrsv
bronchiol
hospit
infanc
retrospect
recruit
nonhospit
control
group
investig
found
children
hospit
bronchiol
infanc
like
control
wheez
versu
year
addit
wheez
parent
report
versu
use
bronchodil
versu
year
initi
bronchiol
episod
common
children
histori
bronchiol
hospit
fjaerli
colleagu
found
group
children
hospit
bronchiol
infanc
whether
rsvposit
rsvneg
like
doctor
care
asthma
age
compar
retrospect
recruit
nonhospit
control
group
children
piipposavolainen
colleagu
also
found
children
hospit
bronchiol
first
year
life
like
asthma
young
adulthood
subset
particip
piipposavolainen
colleagu
found
adult
histori
nonrsv
bronchiol
first
year
life
greater
risk
develop
asthma
compar
adult
histori
rsv
bronchiol
cohort
children
colleagu
investig
relationship
nonrsv
bronchiol
first
year
life
subsequ
risk
asthma
around
age
year
found
rhinovirusposit
hospit
wheez
first
year
life
associ
fourfold
increas
risk
asthma
around
age
year
compar
nonrhinoviru
hospit
final
garciagarcia
colleagu
found
increas
risk
earli
childhood
asthma
children
previous
hospit
hmpv
children
rsv
children
bronchiol
compar
control
group
hospit
gastroenter
children
overal
data
suggest
viral
lrti
virus
rsv
associ
high
even
higher
risk
childhood
asthma
rsvassoci
lrti
limit
number
longitudin
investig
viral
infect
infanc
subsequ
wheez
follow
infant
birth
goal
prospect
identifi
investig
spectrum
acut
respiratori
ill
infanc
earli
childhood
risk
develop
asthma
studi
allow
investig
associ
viral
lrti
requir
hospit
subsequ
wheez
cohort
children
enrol
birth
tucson
children
respiratori
studi
stein
colleagu
found
children
histori
rsv
lrti
first
year
life
time
like
parent
report
infrequ
wheez
one
three
episod
wheez
past
year
time
like
frequent
wheez
three
episod
wheez
past
year
year
compar
infant
lrti
first
year
life
howev
associ
rsv
lrti
infanc
infrequ
frequent
wheez
decreas
age
neither
signific
age
year
age
year
children
follow
first
year
life
includ
investig
suggest
although
rsv
lrti
earli
childhood
risk
factor
recurr
wheez
risk
factor
atop
asthma
lemansk
colleagu
found
rhinoviru
wheez
episod
infanc
strongest
predictor
persist
wheez
preschool
year
among
children
enrol
childhood
origin
asthma
studi
coast
coast
cohort
differ
tucson
cohort
includ
children
increas
risk
develop
asthma
children
cohort
least
one
parent
respiratori
allergi
physiciandiagnos
asthma
investig
found
children
least
one
moder
sever
rhinovirusassoci
wheez
ill
infanc
greater
chanc
subsequ
wheez
third
year
life
rsv
threefold
greater
chanc
wheez
third
year
life
combin
moderatesever
ill
group
without
wheez
increas
risk
wheez
third
year
life
odd
ratio
ci
studi
first
show
particularli
genet
suscept
host
even
moder
sever
viral
infect
infanc
associ
wheez
hospit
associ
increas
risk
subsequ
wheez
anoth
birth
cohort
infant
high
risk
asthma
develop
kusel
colleagu
found
children
histori
wheezi
lrti
infect
rhinoviru
rsv
infanc
increas
risk
wheez
age
year
overview
number
epidemiolog
approach
employ
studi
relationship
viral
infect
asthma
exacerb
tabl
approach
includ
compar
preval
respiratori
virus
detect
asthma
patient
without
acut
exacerb
compar
viru
detect
patient
asthma
patient
without
asthma
commun
emerg
depart
hospit
set
gener
mani
studi
use
sensit
molecular
techniqu
detect
lower
rate
viral
infect
acut
asthma
exacerb
recent
use
pcr
result
increas
detect
respiratori
virus
patient
asthma
exacerb
virus
import
trigger
asthma
exacerb
children
detect
exacerb
children
studi
use
pcr
viral
detect
see
tabl
johnston
colleagu
investig
associ
viral
infect
asthma
exacerb
longitudin
studi
english
children
report
wheez
persist
cough
famili
record
twicedaili
peak
flow
daili
respiratori
symptom
lower
respiratori
symptom
defin
record
cough
day
night
wheez
day
night
difficulti
breath
short
breath
fit
go
school
chest
problem
virus
detect
approxim
report
episod
lrti
associ
decreas
peak
flow
measur
picornavirus
includ
rhinoviru
enterovirus
account
two
third
posit
sampl
comparison
investig
test
respiratori
aspir
picornaviru
group
children
provid
respiratori
sampl
asymptomat
investig
found
sampl
posit
anoth
investig
johnston
colleagu
found
strong
correl
rate
upper
respiratori
tract
infect
divid
halfmonthli
segment
rate
pediatr
adult
hospit
admiss
asthma
determin
intern
classif
diseas
ninth
revis
code
studi
demonstr
high
preval
respiratori
virus
children
asthma
correl
peak
respiratori
infect
asthma
hospit
new
vaccin
surveil
network
populationbas
surveil
investig
hospit
pediatr
patient
age
birth
year
two
unit
state
counti
base
children
enrol
octob
septemb
children
histori
wheez
asthma
significantli
higher
estim
rate
rhinovirusassoci
hospit
children
without
histori
wheez
asthma
children
p
investig
examin
relationship
respiratori
viru
infect
asthma
exacerb
compar
viru
detect
asthma
patient
without
acut
exacerb
thumerel
colleagu
conduct
region
studi
french
children
octob
june
age
year
children
asthma
investig
found
higher
rate
viru
detect
among
hospit
exacerb
compar
without
exacerb
prior
week
khetsuriani
colleagu
studi
children
age
year
persist
asthma
sixtyf
children
acut
asthma
exacerb
children
wellcontrol
asthma
enrol
one
virus
detect
patient
asthma
exacerb
patient
wellcontrol
asthma
rhinoviru
detect
among
case
patient
control
symptomat
respiratori
infect
posit
least
one
viru
associ
asthma
exacerb
asymptomat
infect
observ
studi
also
use
investig
associ
respiratori
virus
asthma
morbid
increas
asthma
hospit
earli
autumn
note
sever
countri
respiratori
virus
particular
rhinoviru
specul
caus
agent
johnston
colleagu
investig
etiolog
septemb
epidem
asthma
exacerb
case
group
canadian
children
asthma
present
emerg
depart
last
week
septemb
compar
group
control
asthma
recruit
commun
although
control
group
emerg
depart
visit
major
report
asthma
symptom
includ
continu
repeat
breath
troubl
respiratori
viral
infect
asthma
wake
night
activ
limit
virus
detect
significantli
larger
proport
children
present
emerg
depart
children
present
emerg
depart
versu
case
also
less
like
control
prescrib
inhal
corticosteroid
separ
studi
johnston
colleagu
use
mathemat
model
investig
relationship
peak
asthma
hospit
canada
return
school
investig
found
studi
year
averag
time
peak
asthma
hospit
schoolag
children
occur
day
follow
return
school
later
peak
preschool
children
adult
investig
conclud
schoolag
children
like
sourc
etiolog
agent
result
yearli
peak
asthma
hospit
plausibl
hypothesi
transmiss
infecti
agent
rhinoviru
virus
import
trigger
asthma
exacerb
adult
studi
use
pcr
detect
virus
approxim
exacerb
see
tabl
studi
teichtahl
colleagu
includ
adult
admit
asthma
exacerb
match
control
admit
elect
surgeri
august
juli
seventynin
patient
asthma
control
includ
overal
adult
admit
asthma
viru
detect
compar
control
group
atmar
colleagu
conduct
longitudin
studi
adult
asthma
recruit
pulmonari
clinic
crosssect
studi
conveni
sampl
adult
present
emerg
depart
asthma
exacerb
virus
detect
use
virusspecif
pcr
investig
found
longitudin
studi
asthma
exacerb
associ
respiratori
tract
viral
infect
crosssect
emerg
depart
studi
associ
viral
infect
rhinoviru
coronaviru
influenza
piv
common
virus
detect
sever
studi
perform
viral
detect
asthma
exacerb
subsequ
followup
use
pcr
tan
colleagu
investig
preval
viral
respiratori
infect
adult
nearfat
asthma
requir
ventilatori
support
adult
hospit
asthma
exacerb
hospit
chronic
obstruct
pulmonari
diseas
sampl
viral
detect
taken
acut
asthma
exacerb
followup
sampl
obtain
week
hospit
discharg
acut
exacerb
overal
sampl
posit
includ
nearfat
asthma
acut
exacerb
nearfat
asthma
group
virus
detect
picornaviru
adenoviru
viral
detect
posit
specimen
collect
week
hospit
admiss
studi
use
molecular
diagnost
techniqu
investig
role
recent
discov
virus
pathogenesi
asthma
exacerb
william
colleagu
determin
preval
hmpv
cohort
adult
initi
enrol
asthma
hospit
followup
month
later
hmpv
detect
subject
admiss
compar
followup
furthermor
none
subject
posit
hmpv
admiss
posit
followup
anoth
studi
involv
cohort
patient
describ
preval
rhinoviru
patient
acut
asthma
exacerb
followup
studi
period
cohort
rhinovirusposit
pcr
asthma
exacerb
seventysix
particip
complet
followup
followup
patient
posit
none
subject
rhinovirusposit
preced
asthma
exacerb
posit
followup
subject
rhinovirusposit
like
smoke
cigarett
nonus
inhal
corticosteroid
compar
rhinovirusneg
subject
similar
find
lower
use
inhal
corticosteroid
among
children
seen
hospit
septemb
asthma
epidem
associ
rhinoviru
corn
colleagu
conduct
longitudin
investig
rhinoviru
infect
follow
subject
asthma
cohabit
partner
without
asthma
period
septemb
decemb
subject
maintain
diari
sever
upper
lower
respiratori
tract
symptom
nasal
aspir
obtain
subject
everi
week
overal
differ
rhinoviru
posit
subject
without
asthma
howev
investig
found
particip
asthma
frequent
clinic
lrti
associ
rhinoviru
control
versu
respect
addit
group
patient
asthma
significantli
higher
sever
score
median
versu
longer
durat
ill
median
day
versu
day
epidemiolog
investig
provid
valuabl
insight
role
respiratori
virus
wheez
ill
children
adult
virus
import
caus
lrti
infanc
earli
childhood
lrti
respiratori
viral
pathogen
identifi
signific
risk
factor
develop
earli
childhood
asthma
rsv
import
pathogen
wheez
ill
infanc
appear
becom
less
commonli
associ
wheez
ill
older
children
newli
appreci
role
nonrsv
lrti
strong
associ
rhinoviru
ill
mark
increas
risk
futur
wheez
among
children
born
parent
asthma
suggest
differenti
asthmagen
respiratori
virus
asthma
pathogenesi
although
unclear
whether
respiratori
virus
induc
asthma
develop
children
sever
infect
infanc
increas
risk
subsequ
wheez
larg
longitudin
studi
hope
help
answer
critic
question
know
whether
respiratori
virus
caus
asthma
present
hope
new
strategi
asthma
prevent
addit
virus
implic
vast
major
signific
diseas
exacerb
import
trigger
asthma
exacerb
children
adult
respiratori
viral
ill
prevent
would
like
decreas
signific
morbid
relat
common
chronic
diseas
